An immunopanel and/or use of macrophage knockout mice would provide more insights into this potentially exciting mechanism of Sirt2-mediated immunosuppression, suggested by a recent study that showed Sirt2 affects the metabolic fitness of T-cells in the microenvironment of patients with advanced non-small cell lung cancer [44]. Here, SIRT2 is linked to non-small cell lung carcinoma.